| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 02/29/2000 | US6031072 Compounds and methods for modulating cell adhesion |
| 02/29/2000 | US6031001 Topical treatment of psoriasis by applying to the skin a composition comprising prostalandin a2 or j2, or a derivative or an alkyl or benzyl ester of either; antiproliferative agents |
| 02/29/2000 | US6030961 Oxyalkylene phosphate compounds and uses thereof |
| 02/29/2000 | US6030952 As human and veterinary medicine, particularly in the treatment of dermatological, rheumatic, respiratory, cardiovascular and ophthalmologic conditions, and in cosmetic compositions |
| 02/29/2000 | US6030948 Hair regeneration compositions for treatment of alopecia and methods of application related thereto |
| 02/29/2000 | US6030835 Methods and composition for identifying group a streptococcus |
| 02/29/2000 | US6030831 Tie ligand homologues |
| 02/29/2000 | US6030629 Photoprotective cosmetic/dermatological compositions comprising synergistic admixture of sunscreen compounds |
| 02/29/2000 | US6030612 Antimicrobial uses of multifunctional enzyme |
| 02/29/2000 | CA2280049A1 Diarylsulfonylurea binding proteins |
| 02/29/2000 | CA2117349C Benzopyrans and related ltb4 antagonists |
| 02/24/2000 | WO2000009690A1 Extracellular adhesive proteins, exadh1 and exadh2 |
| 02/24/2000 | WO2000009551A1 Human chordin-related proteins and polynucleotides encoding them |
| 02/24/2000 | WO2000009537A2 Compounds having growth hormone releasing activity |
| 02/24/2000 | WO2000009512A2 Bipyridine manganese complexes |
| 02/24/2000 | WO2000009511A1 Novel thiazolopyrimidine compounds |
| 02/24/2000 | WO2000009507A1 Phenyl yanthine derivatives |
| 02/24/2000 | WO2000009504A1 Substituted 1,8-naphthyridin-4(1h)-ones as phosphodiesterase 4 inhibitors |
| 02/24/2000 | WO2000009503A1 Integrin receptor antagonists |
| 02/24/2000 | WO2000009492A1 Tace inhibitors |
| 02/24/2000 | WO2000009485A1 Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors |
| 02/24/2000 | WO2000009168A1 A method of transducing mammalian cells, and products related thereto |
| 02/24/2000 | WO2000009130A2 New pharmaceutical uses for nos inhibitors |
| 02/24/2000 | WO2000009129A1 C3a receptor ligands |
| 02/24/2000 | WO2000009126A1 N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders |
| 02/24/2000 | WO2000009124A1 Pyrrolidine derivatives for vision and memory disorders |
| 02/24/2000 | WO2000009109A2 Pipecolic acid derivatives for vision and memory disorders |
| 02/24/2000 | WO2000009070A2 Inhibition of pathogenic processes related to tissue trauma |
| 02/24/2000 | WO2000009018A1 Collagen type i and type iii hemostatic compositions for use as a vascular sealant and wound dressing |
| 02/24/2000 | WO2000002579A3 Component b as angiogenic agent in combination with human growth factors |
| 02/24/2000 | WO1999062538A8 Alpha-keto oxadiazoles as serine protease inhibitors |
| 02/24/2000 | WO1999062504A3 Topical administration of oxazolidinones for transdermal delivery |
| 02/24/2000 | WO1999062459A3 Agents and methods for protection, treatment and repair of connective tissue |
| 02/24/2000 | WO1999048868A3 Heterocyclic classes of compounds for the modulating tyrosine protein kinase |
| 02/24/2000 | CA2344520A1 Pipecolic acid derivatives for vision and memory disorders |
| 02/24/2000 | CA2341216A1 Bipyridine manganese complexes |
| 02/24/2000 | CA2340702A1 Pyrrolidine derivatives for vision and memory disorders |
| 02/24/2000 | CA2340350A1 Phenyl yanthine derivatives |
| 02/24/2000 | CA2340200A1 New pharmaceutical uses for nos inhibitors |
| 02/24/2000 | CA2340182A1 Tace inhibitors |
| 02/24/2000 | CA2340180A1 1-aryl,-3-arylmethyl-1,8-naphthyridn-2(1h)-ones |
| 02/24/2000 | CA2340176A1 Inhibition of pathogenic processes related to tissue trauma |
| 02/24/2000 | CA2340086A1 A method of transducing mammalian cells, and products related thereto |
| 02/24/2000 | CA2340053A1 C3a receptor ligands |
| 02/24/2000 | CA2339748A1 Human stearoyl-coa desaturase-related compositions and methods for treating skin disorders |
| 02/24/2000 | CA2339575A1 Collagen type i and type iii hemostatic compositions for use as a vascular sealant and wound dressing |
| 02/24/2000 | CA2339418A1 Human chordin-related proteins and polynucleotides encoding them |
| 02/24/2000 | CA2339405A1 Extracellular adhesive proteins, exadh1 and exadh2 |
| 02/24/2000 | CA2338878A1 Integrin receptor antagonists |
| 02/24/2000 | CA2335813A1 N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders |
| 02/23/2000 | EP0980866A2 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 02/23/2000 | EP0980424A2 Enzymatic nucleic acids: synthesis, selection and use |
| 02/23/2000 | EP0980374A1 Phosphodiesterase 4-inhibiting diazepinoindolones |
| 02/23/2000 | EP0980369A1 Sulfonamides for treatment of endothelin-mediated disorders |
| 02/23/2000 | EP0980351A1 New benzylamine and phenylethylamine derivatives, processes for preparing the same and their use as medicaments |
| 02/23/2000 | EP0980270A1 Dermal sheath tissue in wound healing |
| 02/23/2000 | EP0980251A1 Tissue factor for influencing blood vessel formation |
| 02/23/2000 | EP0898579B1 Pregnane derivatives with no alpha-17 substitutent, their medicinal use, manufacturing method and its intermediaries and related compounds |
| 02/23/2000 | EP0832063B1 Vitamin d derivatives with c-25 substituents, process for their preparation, intermediate products and their use in preparing medicaments |
| 02/23/2000 | CN1245424A Medicinal composition |
| 02/23/2000 | CN1245399A Method of biological control |
| 02/23/2000 | CN1245398A Method of biological control |
| 02/23/2000 | CN1245072A Ointment for treating burn and scald and its preparing process |
| 02/23/2000 | CN1245052A Whitening, beautifying and skin-protecting cream |
| 02/23/2000 | CN1245051A Sun screening agent and cosmetics containing it |
| 02/23/2000 | CN1049659C Corticotropin releasing factor antagonists |
| 02/23/2000 | CN1049653C Vitamin D3 analogs and pharmaceutical composition containing same |
| 02/23/2000 | CN1049651C Metalloproteinase inhibitors |
| 02/22/2000 | US6028098 Use of cis-or transurocamic acid for the treatment of photodermatoses and immunogenic skin diseases |
| 02/22/2000 | US6028086 Selective inhibitors of phosphodiesterase (pde) type iv or production of tumor necrosis factor (tnf) and as such are useful treatment of asthma, arthritis, bronchitis, chronic obstructive airways disease, psoriasis, allergic rhinitis |
| 02/22/2000 | US6028074 Pyrazolo[3,4-d]pyrimidineone compounds |
| 02/22/2000 | US6028063 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
| 02/22/2000 | US6028060 Treatment of chronic inflammatory diseases with CM101/GBS toxin |
| 02/22/2000 | US6028051 Administering single dose of lysostaphin analogue and lysostaphin for treating endocarditis, bacterimia, kidney infection, lung infection, skin infection, bone infection, burn wound infections, infection of prosthetic devices |
| 02/22/2000 | US6027728 A selection of herbal powder for application to human skin to remove one layer and accelerate replacement; eczema; psoriasis; skin disorders; antiiflammatory agents; antiallergens |
| 02/22/2000 | CA2002834C Cycloalkyl xanthines |
| 02/22/2000 | CA1340906C Fibronectin binding protein as well as its preparation |
| 02/17/2000 | WO2000008202A2 3-methylidenyl-2-indolinone modulators of protein kinase |
| 02/17/2000 | WO2000008141A2 Short oligonucleotides for the inhibition of vegf expression |
| 02/17/2000 | WO2000008140A2 Antisense oligonucleotides for the inhibition of vegf expression |
| 02/17/2000 | WO2000008061A1 Reaction products of hyaluronic acid and natural amino acids and their use in cosmetic and pharmaceutical compositions |
| 02/17/2000 | WO2000007991A1 Amide derivatives useful as inhibitors of the production of cytokines |
| 02/17/2000 | WO2000007980A1 Amide derivatives which are useful as cytokine inhibitors |
| 02/17/2000 | WO2000007977A1 Novel phenylethylamine derivatives, a method for the production thereof and their use as medicaments |
| 02/17/2000 | WO2000007974A1 2-fluoro mutilin derivatives |
| 02/17/2000 | WO2000007972A1 Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders |
| 02/17/2000 | WO2000007620A1 Protease inhibitors for use in the treatment of psoriasis |
| 02/17/2000 | WO2000007611A1 Treatment of central nervous system ischemia or trauma with epidermal growth factor-like polypeptides |
| 02/17/2000 | WO2000007608A1 COMPOSITION AND METHOD OF TREATING DISEASE WITH EXTRACT OF $i(MUSACEAS) |
| 02/17/2000 | WO2000007590A1 INDOLE sPLA2 INHIBITORS |
| 02/17/2000 | WO2000007581A2 Antioxidant, antiproliferous composition, comprising a carnitine and a carotenoid |
| 02/17/2000 | WO2000007558A1 Use of ectoine or ectoine derivatives in cosmetic formulations |
| 02/17/2000 | WO2000007557A1 Cosmetic and dermatological preparations comprising an effective content of bile acids, their salts and/or their derivatives |
| 02/17/2000 | WO2000007548A1 Finely dispersed emulsifier-free systems of the oil-in-water and water-in-oil type |
| 02/17/2000 | WO2000001815A3 Neurotrophic factors |
| 02/17/2000 | WO1999063931A3 Peptidyl-prolyl cis-trans isomerase inhibitors and uses therefor |
| 02/17/2000 | CA2383623A1 3-methylidenyl-2-indolinone modulators of protein kinase |
| 02/17/2000 | CA2343163A1 Composition and method of treating disease with extract of musaceas |
| 02/17/2000 | CA2339485A1 Protease inhibitors for use in the treatment of psoriasis |
| 02/17/2000 | CA2339416A1 Short oligonucleotides for the inhibition of vegf expression |